- Home
- WGS vs EVV Comparison
WGS vs EVV Comparison
Compare WGS & EVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGS
- EVV
- Stock Information
- Founded
- WGS 2017
- EVV 2003
- Country
- WGS United States
- EVV United States
- Employees
- WGS N/A
- EVV N/A
- Industry
- WGS Retail: Computer Software & Peripheral Equipment
- EVV Finance/Investors Services
- Sector
- WGS Technology
- EVV Finance
- Exchange
- WGS Nasdaq
- EVV Nasdaq
- Market Cap
- WGS 1.5B
- EVV 1.2B
- IPO Year
- WGS N/A
- EVV N/A
- Fundamental
- Price
- WGS $68.43
- EVV $10.03
- Analyst Decision
- WGS Strong Buy
- EVV
- Analyst Count
- WGS 5
- EVV 0
- Target Price
- WGS $67.00
- EVV N/A
- AVG Volume (30 Days)
- WGS 753.8K
- EVV 323.7K
- Earning Date
- WGS 10-29-2024
- EVV 01-01-0001
- Dividend Yield
- WGS N/A
- EVV 9.66%
- EPS Growth
- WGS N/A
- EVV N/A
- EPS
- WGS N/A
- EVV N/A
- Revenue
- WGS $267,228,000.00
- EVV N/A
- Revenue This Year
- WGS $43.70
- EVV N/A
- Revenue Next Year
- WGS $16.78
- EVV N/A
- P/E Ratio
- WGS N/A
- EVV N/A
- Revenue Growth
- WGS 29.41
- EVV N/A
- 52 Week Low
- WGS $1.29
- EVV $8.52
- 52 Week High
- WGS $89.11
- EVV $10.07
- Technical
- Relative Strength Index (RSI)
- WGS 51.05
- EVV 38.76
- Support Level
- WGS $71.45
- EVV $9.97
- Resistance Level
- WGS $82.18
- EVV $10.36
- Average True Range (ATR)
- WGS 7.58
- EVV 0.12
- MACD
- WGS -1.36
- EVV -0.03
- Stochastic Oscillator
- WGS 17.21
- EVV 20.93
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.
About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest
Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund may, as a secondary objective, also seek capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure among others.